Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose intrathecal Prialt pilot study for predicting response to pump-based therapy
2009-012928-89Phase 4Completed
- Sponsor
- South Tees Hospitals NHS Foundation Trust
- Start
- Oct 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ziconotide in chronic pain, sponsored by South Tees Hospitals NHS Foundation Trust. Primary endpoints: Reduction in Visual analogue score for pain, Feasibility of bolus ziconotide as predictor of long-term intrathecal response and 2 more. Started Oct 2010; status: completed.
02
Drugs
ziconotide
03
Conditions
chronic pain
Beyond the preview
Go deeper on 2009-012928-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012928-89.